Abstract
Using a sensitive sandwich enzyme-linked immunosorbent assay (ELISA) method, we measured the concentration of total tau protein in the cerebrospinal fluid (CSF) from nine patients with corticobasal degeneration (CBD) in comparison with 12 normal control subjects in order to assess its diagnostic value. The CSF concentration of tau in patients with CBD (0.69, 0.20 ng/ml: mean, SD) was higher than that in the normal controls (0.48, 0.14 ng/ml, P = 0.0076 unpaired t test). This increase in CBD patients may reflect widespread tau pathology in CBD, but should be interpreted with reserve as an aid to diagnosis.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 30 June 1997 Received in revised form: 1 September 1997 Accepted: 7 September 1997
Rights and permissions
About this article
Cite this article
Mitani, K., Furiya, Y., Uchihara, T. et al. Increased CSF tau protein in corticobasal degeneration. J Neurol 245, 44–46 (1997). https://doi.org/10.1007/s004150050173
Issue Date:
DOI: https://doi.org/10.1007/s004150050173